A series of tryptamine analogues bearing a cyclopropylamine unit was prepared, starting from 3-indolyl acetonitriles, through a MeTi(Oi-Pr) 3 -mediated cyclopropanation.
Conformational restrictions: Based on the pharmacophore model for 5-HT(6) receptor ligands (shown), tryptamine analogues bearing a cyclopropyl ring on the α-position of the tryptamine side chain were synthesized and evaluated against 5-HT receptors. N,N-Dimethyl-1-arylsulfonyltryptamine derivatives exhibited promising selectivity for 5-HT(6) over 5-HT(1a) and 5-HT(4) receptors and interesting activity against 5-HT(6) (K(i) =∼0.15 μM; IC(50) =∼0.20 μM).
Several synthetic strategies were developed for the preparation of highly substituted pyrido[2,3-d]pyridazines. We particularly focused on the impact of the pyridine nitrogen atom on pyridazine ring reactivity toward aromatic substitutions, alkylations, or pallado-catalyzed cross-coupling reactions.
Synthesis of New Cyclopropanated Tryptamine Analogues. -A new series of N,N-dimethyltryptamine analogues (III) is prepared by a MeTi(OiPr) 3 -promoted cyclopropanation starting from 3-indolyl acetonitriles (I). Investigations concerning the 5-HT6 binding affinity of (III) are in progress. -(SZALATA, C.; SAPI, J.; SZYMONIAK, J.; BERTUS, P.; GERARD*, S.; Synlett 2008, 10, 1479-1482; Fac. Pharm., Inst. Chim. Mol., CNRS, Univ. Reims-Champagne-Ardenne, F-51096 Reims, Fr.; Eng.) -M. Paetzel 43-124
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.